跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lozanoc 50 mg capsules - TGA Drug Approval Details
Approvals
/
TGA
/
Lozanoc 50 mg capsules
Approved
STANDARD
Lozanoc 50 mg capsules
Mayne Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b6519e3ad43c3bd0
Company
Mayne Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
b6519e3ad43c3bd0
Product Name
Lozanoc 50 mg capsules
Artg Id
216603
Artg Name
Lozanoc 50 mg capsules
Sponsor
Mayne Pharma International Pty Ltd
Company Detail Path
/organization/mayne-pharma-international-pty-ltd
Artg Date
2013-10-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b6519e3ad43c3bd0
Type
Standard
Back to TGA Approvals